The Society of Thoracic Surgeons/ American College of Cardiology Transcatheter Valve Therapies Registry Mitral Module

What this Trial Is About

Researchers are evaluating the safety and real-world outcomes of the transcatheter mitral valve repair (TMVR) procedure through the TVT Registry. Developed by The Society of Thoracic Surgeons (STS) and the American College of Cardiology (ACC), this registry supports a national surveillance system to track characteristics, treatments, and outcomes for patients receiving transcutaneous valve therapies. It aims to monitor quality of care and enable research based on collected data. The registry collects standardized patient-level data submitted by hospitals and healthcare providers. It provides confidential reports to participating centers to help improve care quality and serves as a data infrastructure for post-market studies. The focus is on transcatheter valve therapies, which are emerging treatments for mitral and aortic valve diseases, especially important as these conditions increase with aging populations. Participants' data include information on treatments, adverse events within 30 days, and long-term outcomes. The registry tracks patient safety, device performance, and treatment effectiveness. It addresses issues such as quality of life, independence, and treatment burdens for patients with severe valvular heart disease. Participation involves ongoing data collection with no direct treatment interventions, and the registry supports continuous monitoring and quality assessment.

STS/ACC TVT Registry Mitral Module